Development of Lentiviral Vectors for HIV-1 Gene Therapy with Vif-Resistant APOBEC3G
Strategies to control HIV-1 replication without antiviral therapy are needed to achieve a functional cure. To exploit the innate antiviral function of restriction factor cytidine deaminase APOBEC3G (A3G), we developed self-activating lentiviral vectors that efficiently deliver HIV-1 Vif-resistant mu...
Saved in:
Main Authors: | Krista A. Delviks-Frankenberry (Author), Daniel Ackerman (Author), Nina D. Timberlake (Author), Maria Hamscher (Author), Olga A. Nikolaitchik (Author), Wei-Shau Hu (Author), Bruce E. Torbett (Author), Vinay K. Pathak (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2019-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Potent dual block to HIV-1 infection using lentiviral vectors expressing fusion inhibitor peptide mC46- and Vif-resistant APOBEC3G
by: Krista A. Delviks-Frankenberry, et al.
Published: (2023) -
Development of Lentiviral Vectors Simultaneously Expressing Multiple siRNAs Against CCR5, vif and tat/rev Genes for an HIV-1 Gene Therapy Approach
by: Francesca Spanevello, et al.
Published: (2016) -
Lentiviral Vectors for Ocular Gene Therapy
by: Yvan Arsenijevic, et al.
Published: (2022) -
Lentiviral Vector Gene Transfer to Porcine Airways
by: Patrick L Sinn, et al.
Published: (2012) -
APOBEC3G expression and HIV-1 infection in Burkina Faso
by: Tegwinde Rebeca Compaore, et al.
Published: (2018)